Zusammenfassung
Das Kapitel behandelt alle Formen der Vaskulopathien, sowohl mit ihren extraglomerulären Manifestationen als auch mit ihren speziellen Ausprägungen in der Niere. Es wird ein systematischer Überblick gegeben und in Text und Bild werden die morphologischen und immunpathologischen Besonderheiten der vaskulären Veränderungen detailliert dargestellt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Aubrey-Bassler FK, Sowers N (2012) 613 cases of splenic rupture without risk factors or previously diagnosed disease: a systematic review. BMC Emerg Med 12:11
Baker-LePain JC, Stone DH, Mattis AN, Nakamura MC, Fye KH (2010) Clinical diagnosis of segmental arterial mediolysis: differentiation from vasculitis and other mimics. Arthritis Care Res (Hoboken) 62:1655–1660
Bakhtiari K, Meijers JC, de Jonge E, Levi M (2004) Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32:2416–2421
Barbano B, Gigante A, Amoroso A, Cianci R (2013) Thrombosis in nephrotic syndrome. Semin Thromb Hemost 39:469–476
Barri YM (2008) Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep 10:39–45
Begelman SM, Olin JW (2000) Fibromuscular dysplasia. Curr Opin Rheumatol 12:41–47
Biesenbach P, Gremmel T, Hörl WH, Kain R, Säemann MD (2010) Gross proteinuria and subacute renal failure after coronary angiography – a case report of cholesterol crystal embolization. Wien Klin Wochenschr 122:251–254
Brandenburg VM, Cozzolino M, Ketteler M (2011) Calciphylaxis: a still unmet challenge. J Nephrol 24:142–148
Brunkhorst FM (2006) Epidemiologie, Ökonomie und Praxis-Ergebnisse der deutschen Prävalenzstudie des Kompetenznetwerkes Sepsis (SepNet). Anästhesiol Intensivmed Notfallmed Schmerzther 41:43–44
Burke AP, Virmani R (2001) Localized vasculitis. Semin Diagn Pathol 18:59–66
Caetano ER, Zatz R, Saldanha LB, Praxedes JN (2001) Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension 38:171–176
Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, Watts R, Merkel PA, Luqmani RA (2013) ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol 17:619–621
Dorresteijn JA, Visseren FL, Spiering W (2012) Mechanisms linking obesity to hypertension. Obes Rev 13:17–26
El Karoui K, Hill GS, Karras A, Jacquot C, Moulonguet L, Kourilsky O, Frémeaux-Bacchi V, Delahousse M, Duong Van Huyen JP, Loupy A, Bruneval P, Nochy D (2012) A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol 23:137–148
Fernandez-Fernandez B, Ortiz A, Gomez-Guerrero C, Barat A, Martín-Cleary C, Egido J (2012) Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis? BMC Nephrol 13:21
Gröne HJ, Helmchen U (1986) Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy. Lab Invest 54:645–655
Harris RJ, Cropley TG (2011) Possible role of hypercoagulability in calciphylaxis:review of the literature. J Am Acad Dermatol 64:405–412
Harrison EG Jr, McCormack LJ (1971) Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 46:161–167
Henke PK, Cardneau JD, Welling TH 3rd, Upchurch GR Jr., Wakefield TW, Jacobs LA, Proctor SB, Greenfield LJ, Stanley JC (2001) Renal artery aneurysms: a 35-year clinical experience with 252 aneurysms in 168 patients. Ann Surg 234:454–234
Hernández-Rodríguez J, Tan CD, Rodríguez ER, Hoffman GS (2009) Gynecologic vasculitis: an analysis of 163 patients. Medicine (Baltimore) 88:169–181
Holl-Ulrich K (2010) Histopathology of systemic vasculitis. Pathologe 31:67–76
Jehle AW, Mayr M (2012) Nierenvenenthrombose. Schweiz Med Forum 12:95–98
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11
Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Norris KC, Shlipak MG (2011) Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP). Clin J Am Soc Nephrol 6:1858–1865
Kallenberg CG (2011) Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis:where to go? Clin Exp Immunol 164(Suppl 1):1–3
Kalra PA, Guo H, Gilbertson DT, Liu J, Chen SC, Ishani A, Collins AJ, Foley RN (2010) Atherosclerotic renovascular disease in the United States. Kidney Int 77:37–43
Kang YS (2013) Obesity Associated Hypertension: New Insights into Mechanism. Electrolyte Blood Press 11:46–52
Llach F (1985) Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 28:429–439
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757
Marcantoni C, Fogo AB (2006) A perspective on arterionephrosclerosis: from pathology to potential pathogenesis. J Nephrol 20:518–524
McKenzie GA, Oderich GS, Kawashima A, Misra S (2013) Renal artery fibromuscular dysplasia in 2,640 renal donor subjects: a CT angiography analysis. J Vasc Interv Radiol 24:1477–1480
Nachman PH, Falk RJ, Jeanette JC et al (1999) The kidney in systemic diseases. In: Maluche HH (Hrsg) Clinical nephrology, dialysis and transplantation. Dustri, Deisenhofen, S 1–42 (Kap. I-8)
Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ Jr, Sarnak MJ, Nally JV Jr (2012) Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant 27:3228–3234
Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV Jr (2013) Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol 8:945–952
Noppeney T et al (2010) Varikose: Diagnostik – Therapie – Begutachtung. Springer, Berlin, S 191
Padmanabhan S, Newton-Cheh C, Dominiczak AF (2012) Genetic basis of blood pressure and hypertension. Trends Genet 28:397–408
Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X (2007) Fibromuscular dysplasia. Orphanet J Rare Dis 2:28
Poloskey SL, Olin JW, Mace P, Gornik HL (2012) Fibromuscular dysplasia. Circulation 125:e636–639
Pontes Tde C, Rufino GP, Gurgel MG, Medeiros AC, Freire EA (2012) Fibromuscular dysplasia: a differential diagnosis of vasculitis. Rev Bras Reumatol 52:70–74
Racusen LC, Solez K (1993) Renal cortical necrosis, infarction and atheroembolic disease. In: Tisher C, Brenner B (Hrsg) Renal pathology. Lippincott-Raven, Philadelphia, S 811
Rao MV, Qiu Y, Wang C, Bakris G, Hypertension and CKD (2008) Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999–2004. Am J Kidney Dis 51(Suppl 2):S30–S37 ()
Ross EA (2011) Evolution of treatment strategies for calciphylaxis. Am J Nephrol 34:460–467
Selye H, Gabbiani G, Tuchweber B (1962) Über eine verkalkende Form der anaphylaktoiden Entzündung. Allerg Asthma 8:177–181
Selye H (1962) The dermatologic implications of stress and calciphylaxis. J Invest Dermatol 39:259–275
Shaw A (2011) Models of preventable disease: contrast-induced nephropathy and cardiac surgery associated acute kidney injury. Contrib Nephrol 174:156–162
Symmers WS (1952) Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). Br Med J 2:897–903
Textor SC (2004) Ischemic nephropathy: where are we now? J Am Soc Nephrol 15:1974–1982
Thai LH, Charles P, Resche-Rigon M, Desseaux K, Guillevin L (2014) Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener’s) relapses? Results of a retrospective study on 126 patients. Autoimmun Rev 13:313–318
Toto RD (1994) Renal insufficiency due to angiotensin-converting enzyme inhibitors. Miner Electrolyte Metab 20:193–200
Toto RD (2005) Treatment of hypertension in chronic kidney disease. Semin Nephrol 25:435–439
Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG (2002) African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288:2421–2431
Zeller T, Macharzina R, Rastan A, Beschorner U, Noory E (2014) Renal artery stenosis: Up-date on diagnosis and treatment. Vasa 43:27–38
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Amann, K., Büttner-Herold, M., Kain, R. (2016). Vaskulopathien. In: Amann, K., Kain, R., Klöppel, G. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04566-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-04566-0_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-04565-3
Online ISBN: 978-3-642-04566-0
eBook Packages: Medicine (German Language)